[2-(2,5-dimethoxy-phenyl)-1-methyl-ethyl]-methyl-amine | 54687-43-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: [2-(2,5-dimethoxy-phenyl)-1-methyl-ethyl]-methyl-amine
• 英文别名: 2-Methylamino-1-(2.5-dimethoxy-phenyl)-propan；[2-(2,5-Dimethoxy-phenyl)-1-methyl-aethyl]-methyl-amin；N-Methyl-2,5-dimethoxyamphetamine；Methyl-DMA；1-(2,5-dimethoxyphenyl)-N-methylpropan-2-amine
• CAS: 54687-43-3
• 化学式: C₁₂H₁₉NO₂
• 分子量: 209.288
• InChiKey: RSDBPMOXIPCTPN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  30.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  3-(2,5-dimethoxy-phenyl)-2-methyl-propionic acid amide 在 1,4-二氧六环 、 sodium hypochlorite 作用下， 生成 [2-(2,5-dimethoxy-phenyl)-1-methyl-ethyl]-methyl-amine
  参考文献：
  名称：

  Amines Related to 2,5-Dimethoxyphenethylamine.¹ II

  摘要：

  DOI：

  10.1021/ja01858a047

文献信息

• Immunoassay for Phenethylamines of the 2C and DO Sub-Families
  申请人：Randox Laboratories Limited

  公开号：US20150038366A1

  公开（公告）日：2015-02-05

  Immunoassay methods and their requisite components for the detection and determination of phenethylamines of the 2C and DO sub-families are described.

  描述了用于检测和测定2C和DO亚家族苯乙胺的免疫分析方法及其必要组成部分。
• [EN] PHENALKYLAMINES AND METHODS OF TREATING MOOD DISORDERS<br/>[FR] PHÉNALKYLAMINES ET PROCÉDÉS DE TRAITEMENT DE TROUBLES DE L'HUMEUR
  申请人：GILGAMESH PHARMACEUTICALS INC

  公开号：WO2022006186A1

  公开（公告）日：2022-01-06

  Phenalkylamines and methods of treating mood disorders with phenalkylamines. Also provided are pharmaceutical compositions that include phenalkylamines.

  Phenalkylamines和使用Phenalkylamines治疗情绪障碍的方法。还提供了包含Phenalkylamines的制药组合物。
• IMPROVED METHODS OF AND COMPOSITIONS FOR THE PREVENTION OF ANXIETY, SUBSTANCE ABUSE, AND DEPENDENCE
  申请人：Hythiam, Inc.

  公开号：EP1868593A2

  公开（公告）日：2007-12-26
• Antiparkinsonian Action of Phenylisopropylamines
  申请人：Caron G. Marc

  公开号：US20070027208A1

  公开（公告）日：2007-02-01

  A method of treating a subject for Parkinson's disease comprises administering said subject a phenylisopropylamine in an amount effective to treat said Parkinson's disease. In some embodiments the method is used to treat at least a motor symptom of Parkinson's disease; in some embodiments the method is used to treat at least a non-motor symptom of Parkinson's disease.
• COMPOSITIONS COMPRISING A PSILOCYBIN DERIVATIVE AND A CANNABINOID
  申请人：CaaMTech, LLC

  公开号：US20190142851A1

  公开（公告）日：2019-05-16

  This disclosure pertains to new compositions and methods comprising a psilocybin derivative. In one embodiment, the compositions disclosed herein are used for a method of regulating a neurotransmitter receptor, e.g., a serotonin receptor. In one embodiment, the compositions disclosed herein comprise purified compounds, e.g., a purified psilocybin derivative, a purified cannabinoid, or purified terpene.